RPCONE
GILD icon

Retirement Planning Company of New England’s Gilead Sciences GILD Stock Holding History

Retirement Planning Company of New England’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
11,227
-93
-0.8% -$12.3K 0.51% 49
2026
Q1 		$1.58M Buy
11,320
+4
+0% +$560 0.64% 37
2025
Q4 		$1.39M Sell
11,316
-8
-0.1% -$972 0.56% 45
2025
Q3 		$1.26M Sell
11,324
-37
-0.3% -$4.21K 0.51% 51
2025
Q2 		$1.26M Buy
11,361
+50
+0.4% +$5.32K 0.56% 47
2025
Q1 		$1.27M Buy
11,311
+167
+1% +$17.2K 0.63% 40
2024
Q4 		$1.03M Buy
11,144
+99
+0.9% +$8.91K 0.5% 51
2024
Q3 		$926K Sell
11,045
-1,297
-11% -$99K 0.46% 62
2024
Q2 		$847K Buy
12,342
+858
+7% +$57.3K 0.46% 62
2024
Q1 		$841K Buy
11,484
+564
+5% +$43.4K 0.46% 68
2023
Q4 		$885K Buy
10,920
+616
+6% +$47.9K 0.4% 76
2023
Q3 		$772K Sell
10,304
-590
-5% -$45.4K 0.43% 71
2023
Q2 		$840K Buy
10,894
+10
+0.1% +$798 0.48% 67
2023
Q1 		$903K Sell
10,884
-59
-0.5% -$4.89K 0.55% 60
2022
Q4 		$939K Buy
10,943
+140
+1% +$11.1K 0.61% 51
2022
Q3 		$666K Buy
10,803
+92
+0.9% +$5.8K 0.48% 68
2022
Q2 		$662K Sell
10,711
-2,108
-16% -$131K 0.45% 73
2022
Q1 		$762K Buy
12,819
+1,217
+10% +$77.8K 0.43% 74
2021
Q4 		$842K Buy
+11,602
New +$799K 0.41% 65

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Retirement Planning Company of New England's GILD Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its Gilead Sciences (GILD) stake by 0.82% in Q2 2026, selling an estimated $12.3K and leaving 11,227 shares worth $1.42M. The position accounts for 0.51% of the portfolio, ranked #49.

Retirement Planning Company of New England first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.58M in Q1 2026. 1,731 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Retirement Planning Company of New England held 11,227 shares of Gilead Sciences worth $1.42M as of Q2 2026.
  • Retirement Planning Company of New England sold 93 Gilead Sciences shares in Q2 2026, an estimated $12.3K.
  • Gilead Sciences made up 0.51% of Retirement Planning Company of New England's portfolio in Q2 2026, its #49 holding.
  • Retirement Planning Company of New England first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Retirement Planning Company of New England's Gilead Sciences position peaked at $1.58M in Q1 2026.
  • 1,731 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.